InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Parsey Merdad, Directeur Médical. Director active across 2 companies, notably Gilead Sciences INC. Aggregated, 9 reports have been recorded. The latest transaction was disclosed on 15 February 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations9 total
1,039 shares
Common Stock
SEC:0001127602-22-017322:0·
€16,045348 shares@ €46.10730.0000% mcap100.0% of flow
Common Stock
SEC:0001127602-22-011953:0·
3,455 shares
Common Stock
SEC:0001127602-22-009209:0·
020,298 shares0
Common Stock
SEC:0001127602-22-002465:0·
020,298 shares0
Common Stock
SEC:0001127602-22-002465·
5,100 shares
Common Stock
SEC:0001127602-21-029042·
5,100 shares
Common Stock
SEC:0001127602-21-029042:0·
€471 shares@ €46.6990.0000% mcap100.0% of flow
Common Stock
SEC:0001127602-21-024264·
€471 shares@ €46.6990.0000% mcap50.0% of flow
Common Stock
SEC:0001127602-21-024264:0·
9 of 9 declarations
About Parsey Merdad
Merdad Parsey is the Chief Medical Officer at Gilead Sciences Inc. He is responsible for the company's medical strategy, including research and development of new treatments. His expertise is crucial for innovation in the pharmaceutical sector.
